CMS Open Payments · Program Year 2024
Canon Medical Research USA Inc.
Canon Medical Research USA Inc. reported $247,343.64 across General Payments, Research, and Ownership to 1 physicians and teaching hospitals across 5 transactions.
- $247.3K
- All-tracks total
- 5
- Transactions
- 1
- Recipients
- #941
- of 1,925 companies
Canon Medical Research USA Inc. reported $247,343.64 across all CMS Open Payments tracks (General + Research + Ownership) to 1 physicians and teaching hospitals in Program Year 2024 - ranking #941 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,500.00, averaging $247.3K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer canon-medical-research-usa-inc Canon Medical Research USA Inc.
$247.3K · #941/1,925 · 0.0% industry · PY2024
- TOT $247.3K
- RANK #941
- SHARE 0.0%
- TXN 5
- RCP 1
- CAT 1
- GEN $1.5K
- TOP1 100.0%
- PY 2024
Volume peers
Nearest volume peer: Forestadent USA, Inc. ($247.1K)
Canon Medical Research USA Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Canon Medical Research USA Inc.
In Program Year 2024, Canon Medical Research USA Inc. reported $247,343.64 in payments to 1 physicians and teaching hospitals across 5 individual transactions, an average of $49.5K per transaction and $247.3K per recipient. That total places Canon Medical Research USA Inc. at rank #941 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $1.5K, accounting for 100.0% of this company's General Payments and 1 transactions.
General Payment Breakdown by Type
Canon Medical Research USA Inc. made 1 types of general payments. "Consulting Fee" is the largest category at $1.5K, 100.0% of General Payments.
How Canon Medical Research USA Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $1.5K | 1 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,500.00 (100.0%) of $1,500.00 in this company's General Payments records across 1 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Canon Medical Research USA Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Ruth C Carlos
$1,500.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Canon Medical Research USA Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Canon Medical Research USA Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Canon Medical Research USA Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Purdue Pharmaceuticals L.P.
Sentynl Therapeutics, Inc.
Nico Corporation
Total Joint Orthopedics, Inc.
Vivus LLC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.